Cargando…
Extracorporeal membrane oxygenation in Pneumocystis jirovecii pneumonia: outcome in HIV and non-HIV patients
Autores principales: | Rilinger, Jonathan, Staudacher, Dawid L., Rieg, Siegbert, Duerschmied, Daniel, Bode, Christoph, Wengenmayer, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854795/ https://www.ncbi.nlm.nih.gov/pubmed/31727133 http://dx.doi.org/10.1186/s13054-019-2661-9 |
Ejemplares similares
-
Influence of immunosuppression in patients with severe acute respiratory distress syndrome on veno‐venous extracorporeal membrane oxygenation therapy
por: Rilinger, Jonathan, et al.
Publicado: (2021) -
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial
por: Rieder, Marina, et al.
Publicado: (2021) -
Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience
por: Zotzmann, Viviane, et al.
Publicado: (2019) -
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation
por: Rieder, Marina, et al.
Publicado: (2020) -
Prone positioning in severe ARDS requiring extracorporeal membrane oxygenation
por: Rilinger, Jonathan, et al.
Publicado: (2020)